Posts | Comments | Contact

Cascadian Therapeutics, Inc. (NASD:CASC) Seasonal Chart

Cascadian Therapeutics, Inc. (NASD:CASC) Seasonality

CASC Relative to the S&P 500
CASC Relative to the S&P 500

CASC Relative to the Sector
CASC Relative to the Sector

Monthly Seasonal Cascadian Therapeutics, Inc. (NASD:CASC)

Seasonal Chart Analysis

Analysis of the Cascadian Therapeutics, Inc. (NASD:CASC) seasonal charts above shows that a Buy Date of December 25 and a Sell Date of April 3 has resulted in a geometric average return of 9.23% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 32.43% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Cascadian Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing therapeutic product candidates for the treatment of cancer. Its product candidate is ONT-380, an orally active & selective small molecule HER2 inhibitor.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...